Safety and clinical utility of long-term intravenous milrinone in advanced heart failure
- 1 July 1997
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 80 (1) , 61-64
- https://doi.org/10.1016/s0002-9149(97)00284-1
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Use of milrinone in cardiac surgical patientsCardiovascular Drugs and Therapy, 1993
- Amrinone-associated thrombocytopenia: Pharmacokinetic analysisClinical Pharmacology & Therapeutics, 1993
- Intravenous milrinone in patients with severe congestive cardiac failure awaiting heart transplantationJournal of Cardiothoracic and Vascular Anesthesia, 1992
- Effect of Oral Milrinone on Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1991
- Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1989
- Liver Function Abnormalities in Chronic Heart FailureArchives of internal medicine (1960), 1987
- Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: A multicenter studyJournal of the American College of Cardiology, 1987
- Pharmacokinetics and effects on blood pressure of a single oral dose of milrinone in healthy subjects and in patients with renal impairmentEuropean Journal of Clinical Pharmacology, 1986
- Tolerance to dobutamine after a 72 hour continuous infusionThe American Journal of Medicine, 1980